Allan Ira Levey MD PhD, FANA
Dementia & Geriatrics
Professor and Chairman of the Department of Neurology at Emory University, and he is Director of the Emory Alzheimer’s Disease Research Center. Dr. Levey has secondary faculty appointments in the Departments of Pharmacology and Psychiatry and Behavioral Sciences.
Join to view full profile
1841 PO BoxAtlanta, GA 30322
Phone+1 404-778-3444
Dr. Levey is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Allan Levey is a neurologist and neuroscientist in Atlanta, GA and is a faculty member at Emory University. He received his medical degree and PhD from University of Chicago Pritzker School of Medicine and has been in practice 33 years. He specializes in cognitive neurology.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1986 - 1989
Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1984 - 1985
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1984
Certifications & Licensure
GA State Medical License 1991 - 2027
NC State Medical License 2020 - 2022
MD State Medical License 1989 - 1992
IL State Medical License 1985 - 1987
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Clinical Data Warehouse Meaningful Use, Emory Healthcare, 2013-2014, 2016
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2013-2014, 2016
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013-2014, 2016
Clinical Trials
Publications & Presentations
PubMed
- Performance of the participant self-rating version of the Quick Dementia Rating System in a racially diverse cohort of non-demented older adults.Felicia C Goldstein, Chadwick M Hales, Monica W Parker, Antoine R Trammell, Cecelia M Manzanares
Journal of Alzheimer's Disease. 2026-08-05 - Life's Essential 8: Essential for Brain and Cognitive Health.Matthew E Gold, Sanjay Chandrasekhar, Ambar Kulshreshtha, Michael Britt, Nicole Guynn
Journal of the American Heart Association. 2026-08-04 - Agentic AI for scaling diagnosis and care in neurodegenerative disease.Andrew G Breithaupt, Michael Weiner, Alice Tang, Katherine L Possin, Marina Sirota
Nature Aging. 2026-08-01
Journal Articles
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentIhab Hajjar, Allan Levey, JAMA Network Open
Authored Content
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
Press Mentions
Advancing Research and Care at Alzheimer DayMay 21st, 2025- Alzheimer’s Disease: The Cholinergic RevivalJanuary 29th, 2025
- Emory Receives $22 Million Grant to Research ‘Type 3 Diabetes’October 4th, 2024
Grant Support
- Goizueta Alzheimer's Disease Research CenterEMORY UNIVERSITY2020–2030
- P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in IndiaEMORY UNIVERSITY2024–2029
- P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in IndiaEMORY UNIVERSITY2024–2029
- TREAT ADEMORY UNIVERSITY2019–2029
- Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body DementiaEMORY UNIVERSITY2022–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
